Munich, Germany

Reimar Abraham

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 28(Granted Patents)


Location History:

  • Martinsried, DE (2019 - 2022)
  • Munich, DE (2019 - 2023)

Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Reimar Abraham: A Pioneer in Antibody Therapeutics

Introduction

Reimar Abraham is an innovative inventor based in Munich, Germany, known for his significant contributions to the field of antibody therapeutics. With a portfolio of six patents, Abraham has focused his research on enhancing treatment efficacy and safety in oncology, particularly through the development of novel antibody-drug conjugates.

Latest Patents

Among his latest innovations, Abraham has created a patented combination of an anti-FGFR4 antibody and a bile acid sequestrant. This groundbreaking invention addresses the toxic effects associated with therapies targeting FGFR4 inhibition, specifically by combining FGFR4 inhibitors with agents that reduce bile acid levels, aimed at treating various diseases. Another notable patent is the anti-HER3 antibody-drug conjugate, designed to provide an antitumor drug that excels in therapeutic effectiveness while maintaining a high safety profile. This invention facilitates the conjugation of an antitumor compound to an anti-HER3 antibody, ensuring a targeted approach in cancer treatment.

Career Highlights

Reimar Abraham has made significant strides in the pharmaceutical industry, having worked with esteemed organizations such as Daiichi Sankyo Company, Limited, and Daiichi Sankyo Europe GmbH. His tenure at these companies has allowed him to collaborate on cutting-edge research and development projects, reinforcing his status as a leading inventor in his field.

Collaborations

Throughout his career, Abraham has had the opportunity to collaborate with talented professionals, including coworkers like Thore Hettmann and Sabine Blum. These partnerships have fostered a dynamic environment conducive to innovation, leading to several successful patents that contribute to advancements in the treatment of cancer.

Conclusion

Reimar Abraham's commitment to improving cancer treatment through innovative antibody-based therapies positions him as a notable figure in the realm of biomedical inventions. His recent patents underscore a focused effort to enhance the therapeutic landscape for oncology patients, demonstrating the impactful role of inventors in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…